1. Home
  2. SPXX vs HRTX Comparison

SPXX vs HRTX Comparison

Compare SPXX & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPXX
  • HRTX
  • Stock Information
  • Founded
  • SPXX 2004
  • HRTX 1983
  • Country
  • SPXX United States
  • HRTX United States
  • Employees
  • SPXX N/A
  • HRTX N/A
  • Industry
  • SPXX Trusts Except Educational Religious and Charitable
  • HRTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SPXX Finance
  • HRTX Health Care
  • Exchange
  • SPXX Nasdaq
  • HRTX Nasdaq
  • Market Cap
  • SPXX 322.7M
  • HRTX 276.1M
  • IPO Year
  • SPXX N/A
  • HRTX 1987
  • Fundamental
  • Price
  • SPXX $18.09
  • HRTX $1.35
  • Analyst Decision
  • SPXX
  • HRTX Strong Buy
  • Analyst Count
  • SPXX 0
  • HRTX 2
  • Target Price
  • SPXX N/A
  • HRTX $4.50
  • AVG Volume (30 Days)
  • SPXX 51.3K
  • HRTX 2.6M
  • Earning Date
  • SPXX 01-01-0001
  • HRTX 08-08-2025
  • Dividend Yield
  • SPXX 7.55%
  • HRTX N/A
  • EPS Growth
  • SPXX N/A
  • HRTX N/A
  • EPS
  • SPXX N/A
  • HRTX N/A
  • Revenue
  • SPXX N/A
  • HRTX $149,694,000.00
  • Revenue This Year
  • SPXX N/A
  • HRTX $10.62
  • Revenue Next Year
  • SPXX N/A
  • HRTX $12.99
  • P/E Ratio
  • SPXX N/A
  • HRTX N/A
  • Revenue Growth
  • SPXX N/A
  • HRTX 9.78
  • 52 Week Low
  • SPXX $13.57
  • HRTX $1.04
  • 52 Week High
  • SPXX $16.05
  • HRTX $2.68
  • Technical
  • Relative Strength Index (RSI)
  • SPXX 57.76
  • HRTX 36.48
  • Support Level
  • SPXX $17.73
  • HRTX $1.33
  • Resistance Level
  • SPXX $18.20
  • HRTX $1.43
  • Average True Range (ATR)
  • SPXX 0.15
  • HRTX 0.07
  • MACD
  • SPXX -0.00
  • HRTX 0.02
  • Stochastic Oscillator
  • SPXX 76.60
  • HRTX 45.45

About SPXX Nuveen S&P 500 Dynamic Overwrite Fund

Nuveen S&P 500 Dynamic Overwrite Fund is a diversified closed-end management investment company. Its investment objective is to seek attractive total returns with less volatility than the S&P 500 Index by investing in a U.S. equity portfolio that seeks to substantially replicate the price movements of the S&P 500 Index, as well as selling call options on approximately 35%-75% of the notional value of the Fund's equity portfolio in an effort to enhance the Fund's risk-adjusted returns.

About HRTX Heron Therapeutics Inc.

Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

Share on Social Networks: